HUMAN IgM ANTIBODY INDUCING APOPTOSIS IN HIV-INFECTED CELLS AND REMEDY FOR HIVINFECTION

Details for Australian Patent Application No. 2003244158 (hide)

Owner OKADA, Noriko OKADA, Hidechika

Inventors OKADA, Noriko; OKADA, Hidechika

Pub. Number AU-A-2003244158

PCT Number PCT/JP03/08305

PCT Pub. Number WO2004/003021

Priority 2002-227953 01.07.02 JP; 2003-74316 18.03.03 JP

Filing date 30 June 2003

Wipo publication date 19 January 2004

International Classifications

C07K 016/18 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C12N 015/13 Mutation or genetic engineering - Immunoglobulins

A61P 031/18 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

C12N 005/16 Undifferentiated human, animal or plant cells, e.g. cell lines - Animal cells

Event Publications

18 September 2003 Complete Application Filed

  Priority application(s): 2002-227953 01.07.02 JP; 2003-74316 18.03.03 JP

4 March 2004 Application Open to Public Inspection

  Published as AU-A-2003244158

17 March 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003244159-HUMAN IgM ANTIBODY LYSING ACTIVATED LYMPHOCYTES UNDER MEDIATION BY HOMOLOGOUS COMPLEMENT

2003244157-PROCESS FOR PRODUCING SUSTAINED-RELEASE COMPOSITION